Dima D, Jogia J, Collier D, Vassos E, Burdick KE, Frangou S. CACNA1C and ANK3 risk-genes for bipolar disorder independently modulate engagement and connectivity of the face network during affect processing. JAMA Psychiatry. 2013;70 (12):1303-11. PMID: 24108394


Frangou S. Snipping at the endophenotypic space. Am J Psychiatry. 2013; 170(11): 1223-5. PMID: 24185234


Papachristou E, Ormel J, Oldehinkel AJ, Kyriakopoulos M, Reinares M, Reichenberg A, Frangou S. Child Behavior Checklist—Mania Scale (CBCL-MS): Development and Evaluation of a Population-Based Screening Scale for Bipolar Disorder. PLoS ONE 8(8): e69459 PMID: 23967059


Papachristou E, Frangou S, Reichenberg A. Expanding conceptual frameworks: Life course risk modelling for mental disorders. Psychiatry Res 206(2-3):140-5. PMID: 23127538


Frangou S. Neurocognition in early-onset schizophrenia. Child Adolesc Psychiatr Clin N Am. 2013;22(4):715-26. PMID: 24012082


Delvecchio G, Sugranyes G, Frangou S. Evidence of diagnostic specificity in the neural correlates of facial affect processing in bipolar disorder and schizophrenia: a meta-analysis of functional imaging studies. Psychol Med. 2013; 43(3):553-69. PMID: 22874625

Brambilla P, Perlini C, Bellani M, Tomelleri L, Ferro A, Cerruti S, Marinelli V, Rambaldelli G, Christodoulou T, Jogia J, Dima D, Tansella M, Balestrieri M,  Frangou S. Increased salience of gains versus decreased associative learning differentiate bipolar disorder from schizophrenia during incentive decision making. Psychol Med. 2013; 43(3):571-80. PMID: 22687364

Reinares M, Papachristou E, Harvey P, Mar Bonnín C, Sánchez-Moreno J, Torrent C, Ayuso-Mateos JL, Ploubidis GB, Vieta E, Frangou S. Towards a clinical staging for bipolar disorder: Defining patient subtypes based on functional outcome. J Affect Disord. 2013; 144(1-2):65-71.


Reinares M, Rosa AR, Franco C, Goikolea JM, Fountoulakis K, Siamouli M, Gonda X, Frangou S, Vieta E. A systematic review on the role of anticonvulsants in the treatment of acute bipolar depression. Int J Neuropsychopharmacol. 2013;16(2):485-96. PMID: 22575611


Cheema N, Frangou S, McCrone P. Cost-effectiveness of ethyl-eicosapentaenoic acid in the treatment of bipolar disorder. Ther Adv Psychopharmacol. 2013;3(2):73-81. PMID: 24167678


Frey BN, Andreazza AC, Houenou J, Jamain S, Goldstein BI, Frye MA, Leboyer M, Berk M, Malhi GS, Lopez-Jaramillo C, Taylor VH, Dodd S, Frangou S, Hall GB, Fernandes BS, Kauer-Sant'anna M, Yatham LN, Kapczinski F, Young LT. Biomarkers in bipolar disorder: A positional paper from the International Society for Bipolar Disorders Biomarkers Task Force. Aust N Z J Psychiatry 47(4):321-32. PMID: 23411094

Visitors Count


To learn more about our research or to participate in our studies email us at


or call us on


212 659 1668


Print | Sitemap
© FrangouGroup

This website was created using IONOS MyWebsite.